WHO: Indian strain of COVID-19 resistant to antibodies
Mutations of the Indian strain of COVID-19 indicate its high infectivity and resistance to antibodies in both those who have been ill and vaccinated, the World Health Organization reported.
New varieties of the virus have been discovered in India, including B.1.617. It is a variant with mutations E484Q and L452R that was first identified in India from samples collected on December 1, 2020.
According to preliminary research results, the L452R mutation may interfere with the effectiveness of certain monoclonal antibody treatments. E484Q can neutralize antibodies. Thus, the antibodies that have appeared in a person who has recovered from COVID-19 will not help in the fight against Indian mutations.
Moreover, the new strain is also thought to be highly virulent, which means it is more likely to infect and cause disease.
WHO experts have not yet figured out what influenced the virus mutations in India. One of the factors could be the holding of mass events that increased its spread, as well as the mitigation of antiquated measures in the country.




















Firebird and the Government of Kazakhstan Sign Strategic Agreements to Advance National AI Infrastru...
''Teach For Armenia'' is the June beneficiary of the ''Power of One Dram''
Ucom and Impact Hub Yerevan Continue Supporting the Development of Green Startups in Armenia
''Do not trust your eyes’’: IDBank warns about fraud using deepfakes
Ucom Is the Technology Partner of the Street Ball Armenia Cup 2026
Up to 30% idcoin at pools: Idram&IDBank
Moody's Ratings affirms Unibank’s B1 ratings with a stable outlook
Top Travel Destinations of 2026: IDBank
Idram and Glovo Sign Memorandum of Cooperation in Barcelona
Moody’s Reaffirms ZCMC’s B2 Credit Rating with Stable Outlook